A delicate operation that involved placing a gene into the brain was found to reduce the severity of motor symptoms in patients with moderately advanced Parkinson’s disease, whose symptoms were no longer controlled by their medications.

In a phase I gene therapy trial led by UC San Francisco, 15 patients were able to acquire up to three hours daily of extra “on-time” – the period in which their medication was effective without causing the involuntary muscle movements known as dyskinesia, a frequent side effect of longer-term medication use.

[img][/img]Additionally, patients were able to decrease their Parkinson’s medication by up to 42 percent, depending on the amount of the brain that was infused and the dose of therapy.

For the study,...

http://haleplushearty.org/2019/03/23/gene-therapy-shows-initial-promise-for-parkinsons-disease/


[url]haleplushearty.org[/url]